NO20073728L - Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans - Google Patents

Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans

Info

Publication number
NO20073728L
NO20073728L NO20073728A NO20073728A NO20073728L NO 20073728 L NO20073728 L NO 20073728L NO 20073728 A NO20073728 A NO 20073728A NO 20073728 A NO20073728 A NO 20073728A NO 20073728 L NO20073728 L NO 20073728L
Authority
NO
Norway
Prior art keywords
active substance
release formulation
immediate release
poorly water
oral immediate
Prior art date
Application number
NO20073728A
Other languages
English (en)
Norwegian (no)
Inventor
Rajesh Jain
Marius L De Winter
Sukhjeet Singh
Rohit Kumar
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/056970 external-priority patent/WO2006067150A1/en
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20073728L publication Critical patent/NO20073728L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20073728A 2004-12-23 2007-07-18 Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans NO20073728L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63811104P 2004-12-23 2004-12-23
EP04106933 2004-12-23
PCT/EP2005/056970 WO2006067150A1 (en) 2004-12-23 2005-12-20 Oral immediate release formulation of a poorly watersoluble active substance

Publications (1)

Publication Number Publication Date
NO20073728L true NO20073728L (no) 2007-07-18

Family

ID=35890662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073728A NO20073728L (no) 2004-12-23 2007-07-18 Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans

Country Status (4)

Country Link
KR (1) KR20070104890A (ko)
DE (1) DE602005019919D1 (ko)
IL (1) IL183554A (ko)
NO (1) NO20073728L (ko)

Also Published As

Publication number Publication date
IL183554A0 (en) 2007-09-20
KR20070104890A (ko) 2007-10-29
IL183554A (en) 2011-07-31
DE602005019919D1 (de) 2010-04-22

Similar Documents

Publication Publication Date Title
NO20052335L (no) Dispergerbare deferacirox-tabletter
RS51756B (sr) Čvrste farmaceutske formulacije koje sadrže telmisartan
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
UA100966C2 (ru) Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
PA8625001A1 (es) Composiciones de pelicula
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
TW200744654A (en) Improved oral compositions comprising zinc citrate and/or tocopherol agents
CY1107384T1 (el) Ταχεως διασπειρομενες μορφες δοσομετρησεως ανευ ζελατινης
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
NO20083027L (no) Kontrollert frigivelses-fastformpreparat
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
NO20064808L (no) Orale matrixformuleringer med licarbazepin
HUP0204202A2 (hu) Ibuprofent tartalmazó hatóanyag-preparátum, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
TW200633713A (en) Oral immediate release formulation of a poorly water-soluble active substance
NO20073728L (no) Oral umiddelbar frigivelsesformulering av en darlig vannloselig aktiv substans
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
NO20064834L (no) Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application